Cryo-Cell International (NYSEAMERICAN:CCEL) Stock Price Passes Below 200-Day Moving Average – Time to Sell?

Cryo-Cell International Inc. (NYSEAMERICAN:CCEL)’s stock price crossed below its 200-day moving average during trading on Wednesday . The stock has a 200-day moving average of $3.86 and traded as low as $2.72. Cryo-Cell International shares last traded at $2.97, with a volume of 14,239 shares changing hands.

Cryo-Cell International Stock Down 4.2%

The stock has a fifty day moving average of $3.30 and a 200-day moving average of $3.86. The firm has a market capitalization of $23.94 million, a P/E ratio of -9.58 and a beta of 0.55.

Cryo-Cell International (NYSEAMERICAN:CCEL) last issued its quarterly earnings data on Friday, February 27th. The company reported ($0.47) EPS for the quarter. The business had revenue of $7.84 million for the quarter.

Institutional Inflows and Outflows

A hedge fund recently bought a new stake in Cryo-Cell International stock. Susquehanna International Group LLP bought a new stake in shares of Cryo-Cell International Inc. (NYSEAMERICAN:CCEL) during the third quarter, according to its most recent 13F filing with the SEC. The institutional investor bought 11,062 shares of the company’s stock, valued at approximately $51,000. Susquehanna International Group LLP owned 0.14% of Cryo-Cell International at the end of the most recent quarter. Institutional investors and hedge funds own 10.44% of the company’s stock.

About Cryo-Cell International

Cryo-Cell International, Inc is a pioneering provider of umbilical cord blood and tissue preservation services. Headquartered in Oldsmar, Florida, the company was founded in 1989 as the first private cord blood bank in the United States. Cryo-Cell operates FDA-registered and AABB-accredited laboratory facilities, maintaining stringent quality control measures and cryogenic storage systems to safeguard stem cell viability over long-term storage periods.

The company’s primary business activity centers on the collection, processing and secure storage of newborn stem cell sources harvested at birth.